Bullard also tells CNBC he's sticking with his prediction that the Fed should start hiking interest rates late in the first quarter of 2015.» Read More
Third-generation money manager Sam Stovall, chief equity strategist at S&P Capital IQ, tells CNBC he doesn't let his emotions rule his stock picks.
"Customers should be allowed to buy products that fit their need," the Florida Republican says.
The Fed "tried to say very explicitly" that "the expectations have not changed," Philly Fed President Charles Plosser tells CNBC.
Sam Stovall, S&P Capital IQ chief equity strategist, explains why he takes a look back at historical trends to see whether it's time to pull or sell in a market decline.
Charles Plosser, Philadelphia Fed president & CEO, shares his thoughts on raising the Federal Funds rate. There's a gradual adjustment process to get us there, says Plosser.
Mother Nature seems to be against the operation, reports CNBC's Sri Jegarajah with the latest details on the search for missing flight MH370.
There's a lot of evidence and surveys that suggested six months is not a wildly unexpected time frame, says Charles Plosser, Philadelphia Fed president & CEO, weighing in on comments made by Janet Yellen on rates, but economic conditions is a much better way to think about it, Plosser explains.
Marcus Lemonis, CNBC's "The Profit" star, and Camping World CEO, explains what happened when he tried to help a toy company make a comeback.
We've seen an increase in "cybermischief" over the past few years, says William Plummer, Huawei vice president of external communications, discussing allegations that the NSA spied on Chinese telecom giant Huawei. There is a growing mistrust among technology information networks, Plummer adds.
"Too Big to Fail" author Andrew Ross Sorkin, who's also co-host of CNBC's "Squawk Box," talked about the new drama for Showtime that he collaborated on with the writers of "Oceans Thirteen" and "Rounders."
Julian Emanuel, UBS, and Sarat Sethi, Douglas C. Lane & Associates, provides growth plays which include industrials and data storage. You want to be part of the group that is spending money, says Sethi.
A high-priced drug sold by Gilead Sciences is under lawmakers' scrutiny. But one analyst says there's a bigger problem.
2014's stock market leaders and Big Momentum names fall amid fears of rising rates and market frothiness.
Wintergreen Advisers sent a letter to Coca-Cola's board to protest the company's proposed 2014 equity plan for top executives, reports CNBC's Sara Eisen.
The IPO rush is gathering steam this week. Is there a bubble?
Kimco Realty CEO David Henry thinks it's a possibility someday, and that's just one of his three reasons why strip malls will survive and thrive.
CNBC's Jim Cramer and "Squawk Box's" Joe Kernen share their bracket standings.
Wintergreen Advisers sent a letter to Coca-Cola's board to protest the company's proposed 2014 equity plan for top executives. CNBC's Jim Cramer, shares his opinions.
Discussing Federal Reserve monetary policy's impact on the economy, with Peter Fisher, BlackRock Investment Institute.
U.S. lawmakers sent a letter to Gilead requesting information on pricing for its hepatitis c drug Sovaldi. Christopher Raymond of R.W. Baird.
Get the best of CNBC in your inbox